8.6 C
New York
Thursday, July 29, 2021
Home Health & Fitness Health Canada approves first rapid antigen COVID-19 test

Health Canada approves first rapid antigen COVID-19 test

Health Canada regulators today approved another rapid COVID-19 test — the first antigen device to receive the necessary approvals for use in this country.

U.S.-based Abbott Laboratories can now sell and distribute the Panbio COVID-19 Ag Rapid Test Device, which can produce results in less than 20 minutes.

The test is advertised as a solution for mass testing in “decentralized settings.” Health Canada has authorized it as a point of care test, meaning it can be used by trained professionals in pharmacies, walk-in clinics or doctors’ offices.

While the U.S. Food and Drug Administration authorized two antigen testing devices months ago, Health Canada has been reluctant to put its stamp of approval on such tests.

Public health experts and Ontario Premier Doug Ford have been urging the regulators to make more testing options available as the province grapples with hours-long lines at hospital-run testing centres and a backlog of tens of thousands of samples to be tested.

Molecular test approved by Health Canada last week

Health Canada approved another Abbott rapid test last week, the ID NOW, which is the molecular test that has been used at U.S. President Donald Trump’s White House to screen staff since April.

The Panbio is designed to give “preliminary test results,” and, according to Abbott, a negative result “doesn’t preclude SARS-CoV-2 infection.” 

The company warns that such a test “cannot be used as the sole basis for treatment or other management decisions.”

The test is already in use in major Western countries, like France, where it is used to quickly identify those who have been infected in airports or hospital reception areas.

The antigen rapid tests — which, depending on the device, use matter collected from a nasal or throat swab — don’t require the use of a lab to generate results.

Tests considered less accurate than PCR

While much faster, these tests are considered to be less accurate than the “gold standard” — the polymerase chain reaction (PCR) testing process currently in use across Canada.

If administered properly, PCR tests are highly accurate, identifying positive cases nearly 100 per cent of the time.

Antigen tests, which detect the presence of viral proteins in a biological sample, are also considered highly accurate but they are not as sensitive as molecular PCR tests run through a lab.

Preliminary results from a clinical study conducted by Abbott on 241 samples found that the Panbio COVID-19 Ag test has a sensitivity rate of 93.3 per cent in people suspected of having been exposed to COVID-19 or showing symptoms in the past seven days.

Source link

Today news
Today News 1 runs four of the western GTA’s most influential media websites, offering news, food, lifestyle and entertainment coverage for millions to the Golden Horseshoe and GTA regions. The independently-run, online news source was founded in 2019 and specializes in everything from breaking news to food and restaurant, arts and entertainment and lifestyle coverage.


Please enter your comment!
Please enter your name here

- Advertisment -

Most Popular

Matt Damon on his new film, Stillwater, and why there’s ‘no diplomacy’ between him and Ben Affleck

People like Matt Damon. Whether he's playing Jason Bourne, Mr. Ripley, Private Ryan or Will Hunting, Damon is an actor that moviegoers are...

It took over a year for cross-border concertgoers to finally see ticket refunds

Luc Noel and Bronwen Stenger had separate plans to attend concerts in Michigan, and each bought tickets before the pandemic began. Neither anticipated it...

ZZ Top bassist Dusty Hill dies in his sleep at 72

ZZ Top bassist Dusty Hill, one of the Texas blues rock trio's bearded figures, died at his Houston home, the band announced Wednesday....

Animated children’s series Arthur to end in 2022

After almost 25 years in production, beloved animated series Arthur will debut its final season in winter 2022. In an email statement...

Recent Comments